Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.

Abstract:

:The possibility that hypercalciuria could cause calcium stone formation through a mechanism other than by increasing urinary saturation of stone-forming calcium salts was explored. The effect of increasing calcium concentration on the inhibitor activity against the spontaneous precipitation of calcium oxalate was examined in whole urine (in the presence of naturally occurring inhibitors) and in synthetic media (with added inhibitors). In 11 patients with calcium nephrolithiasis, the induced hypercalciuria from calcium supplementation (600 mg/day) caused a significant fall in the urinary inhibitory activity against calcium oxalate precipitation, as shown by a decline in the formation product ratio from 12.6 +/- 1.1 SEM to 9.6 +/- 1.4 (P less than 0.005). In order to more fully explore this observation, the effect of increasing calcium concentration on the inhibitory activities of citrate (2 mM), chondroitin sulfate (0.05 mg/liter) and a heterogeneous group of naturally-occurring urinary inhibitors (1.0 mg/liter) against calcium oxalate precipitation was examined in vitro in synthetic solutions. The inhibitory actions of both citrate and chondroitin sulfate were significantly attenuated by increasing calcium concentration from 0.25 mM to 6.0 mM (P less than 0.01). However, raising the calcium concentration in synthetic media containing a mixture of partially purified urinary inhibitors produced a significant rise in the urinary inhibitory activity of this macromolecular mixture (P less than 0.01). We conclude that hypercalciuria can attenuate the inhibitory activities of citrate and chondroitin sulfate against calcium oxalate precipitation while at the same time accentuating the inhibitory activity of naturally-occurring urinary inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)

journal_name

Kidney Int

journal_title

Kidney international

authors

Zerwekh JE,Hwang TI,Poindexter J,Hill K,Wendell G,Pak CY

doi

10.1038/ki.1988.100

subject

Has Abstract

pub_date

1988-05-01 00:00:00

pages

1005-8

issue

5

eissn

0085-2538

issn

1523-1755

pii

S0085-2538(15)34260-5

journal_volume

33

pub_type

杂志文章
  • Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.

    abstract::In April 2006, Japan's health insurance system instituted a bundling policy that included recombinant human erythropoietin (rHuEPO) in outpatient hemodialysis therapy. To evaluate outcomes of this, we analyzed a prospective cohort of hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study, in ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2010.382

    authors: Hasegawa T,Bragg-Gresham JL,Pisoni RL,Robinson BM,Fukuhara S,Akiba T,Saito A,Kurokawa K,Akizawa T

    更新日期:2011-02-01 00:00:00

  • In vivo unaltered muscle protein synthesis in experimental chronic metabolic acidosis.

    abstract::Chronic metabolic acidosis (CMA) is a major cause of growth defect, implying disturbances of protein metabolism. Previously, in vivo studies performed in the fasting state showed enhanced whole body protein turnover, whereas in vitro studies showed unchanged muscle protein synthesis. The present study is the first to ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1994.472

    authors: Maniar S,Laouari D,Dechaux M,Motel V,Yvert JP,Mathian B,Kleinknecht C

    更新日期:1994-12-01 00:00:00

  • The role of mitochondria in ischemia/reperfusion injury in organ transplantation.

    abstract::In organ transplantation, ischemia/reperfusion (I/R) results in damage that may affect cell viability and lead to organ failure. I/R injury involves a complex cascade of events, including loss of energy, derangement of the ionic hemostasis, production of reactive oxygen species, and cell death. In this context, mitoch...

    journal_title:Kidney international

    pub_type: 杂志文章,评审

    doi:10.1111/j.1523-1755.2004.761_9.x

    authors: Jassem W,Heaton ND

    更新日期:2004-08-01 00:00:00

  • Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis.

    abstract:BACKGROUND:In interstitial fibrosis, monocytes and myofibroblasts have been directly implicated in scarring, apoptosis, and tissue necrosis. While much has been done to explore the role of these cell types individually in fibrosis, the interactive dependency of monocytes and myofibroblasts has been only marginally expl...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2003.00871.x

    authors: Rodgers KD,Rao V,Meehan DT,Fager N,Gotwals P,Ryan ST,Koteliansky V,Nemori R,Cosgrove D

    更新日期:2003-04-01 00:00:00

  • Developmental regulation and partial-length cloning of tubulointerstitial nephritis antigen of murine metanephros.

    abstract::Tubulointerstitial nephritis antigen (TIN-ag) is an extracellular matrix (ECM) glycoprotein that has been recently isolated and cloned from the rabbit kidney. It is an integral component of the basal lamina, and unlike other basement membrane proteins it is exclusively expressed in the tubular basement membranes (TBMs...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1997.375

    authors: Kumar A,Ota K,Wada J,Wallner EI,Charonis AS,Carone FA,Kanwar YS

    更新日期:1997-09-01 00:00:00

  • Endothelial nitric oxide synthase: from structure to function in one aspartic substitution.

    abstract::Cherney and co-workers examine the functional phenotype of the G894T eNOS polymorphism in a selected group of apparently healthy subjects. The investigators used L-arginine infusion and induced changes in renal hemodynamics. While L-arginine increased effective plasma flow and glomerular filtration rate in GG subjects...

    journal_title:Kidney international

    pub_type: 评论,杂志文章

    doi:10.1038/ki.2008.605

    authors: Goligorsky MS

    更新日期:2009-02-01 00:00:00

  • Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

    abstract:BACKGROUND:Renal failure and toxic acute tubular necrosis (ATN) may be seen following exposure to a variety of therapeutic agents. Zoledronate (Zometa) is a new, highly potent bisphosphonate used in the treatment of hypercalcemia of malignancy. We report the first clinical-pathologic study of nephrotoxicity associated ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2003.00071.x

    authors: Markowitz GS,Fine PL,Stack JI,Kunis CL,Radhakrishnan J,Palecki W,Park J,Nasr SH,Hoh S,Siegel DS,D'Agati VD

    更新日期:2003-07-01 00:00:00

  • Vintage, nutritional status, and survival in hemodialysis patients.

    abstract:BACKGROUND:The link between dialysis "vintage" (length of time on dialysis in months to years) and survival has been difficult to define, largely because of selection effects. End-stage renal disease (ESRD) is thought to be a wasting illness, but there are no published reports describing the associations between vintag...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2000.00945.x

    authors: Chertow GM,Johansen KL,Lew N,Lazarus JM,Lowrie EG

    更新日期:2000-03-01 00:00:00

  • Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion.

    abstract::Hypercalciuria is one of the early manifestations of diabetic nephropathy. We explored here the role of α-Klotho, a protein expressed predominantly in distal convoluted tubules that has a role in calcium reabsorption. We studied 31 patients with early diabetic nephropathy and compared them with 31 patients with IgA ne...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2011.423

    authors: Asai O,Nakatani K,Tanaka T,Sakan H,Imura A,Yoshimoto S,Samejima K,Yamaguchi Y,Matsui M,Akai Y,Konishi N,Iwano M,Nabeshima Y,Saito Y

    更新日期:2012-03-01 00:00:00

  • A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.

    abstract:BACKGROUND:Torsemide has predictable absorption compared to furosemide. Thereby, torsemide results in more constant exposure to active drug. Our hypothesis was that this pharmacokinetic difference between these commonly used loop diuretics may translate into disparate antihypertensive responses in patients with chronic...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1523-1755.2003.00124.x

    authors: Vasavada N,Saha C,Agarwal R

    更新日期:2003-08-01 00:00:00

  • Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients.

    abstract::Zhang et al. found that plasma concentrations of the thiamine antimetabolite oxythiamine are significantly increased in patients with end-stage renal disease. These investigators discuss the potential sources of oxythiamine and the consequences of its plasma elevation. This commentary addresses the significance of the...

    journal_title:Kidney international

    pub_type: 评论,杂志文章

    doi:10.1016/j.kint.2016.04.017

    authors: Moradi H,Said HM

    更新日期:2016-08-01 00:00:00

  • Expression of CR1 (CD35) mRNA in podocytes from adult and fetal human kidneys.

    abstract::The presence of CR1 mRNA in podocytes was investigated using a 35S-labeled CR1 cDNA probe and in situ hybridization in sections from fetal and adult human kidneys. CR1 mRNA was only detected in immature podocytes at early stages of glomerular differentiation in the fetal kidney. In contrast, CR1 antigen was abundantly...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1990.198

    authors: Appay MD,Kazatchkine MD,Levi-Strauss M,Hinglais N,Bariety J

    更新日期:1990-08-01 00:00:00

  • Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.

    abstract::Progressive kidney fibrosis precedes end-stage renal failure in up to a third of patients with diabetes mellitus. Elevated intra-renal transforming growth factor-beta (TGF-beta) is thought to underlie disease progression by promoting deposition of extracellular matrix and epithelial-mesenchymal transition. GW788388 is...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/sj.ki.5002717

    authors: Petersen M,Thorikay M,Deckers M,van Dinther M,Grygielko ET,Gellibert F,de Gouville AC,Huet S,ten Dijke P,Laping NJ

    更新日期:2008-03-01 00:00:00

  • Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.

    abstract::It is no a secret that we are confronted by an alarmingly increasing number of patients with progressive renal disease. There is ample evidence for the notion that angiotensin II (Ang II) is a major culprit in progression. The vasopeptide Ang II turned out to have also multiple nonhemodynamic pathophysiologic actions ...

    journal_title:Kidney international

    pub_type: 杂志文章,评审

    doi:10.1111/j.1523-1755.2005.00145.x

    authors: Wolf G,Ritz E

    更新日期:2005-03-01 00:00:00

  • Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.

    abstract:BACKGROUND:Inbred miniature swine treated for 12 days with high-dose cyclosporine A develop tolerance to histocompatibility complex (MHC) class I-mismatched renal allografts. When this protocol was modified by adding thymectomy before transplant, all animals developed acute rejection. Thereafter, by day 100, one half d...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2000.00440.x

    authors: Shimizu A,Yamada K,Sachs DH,Colvin RB

    更新日期:2000-12-01 00:00:00

  • Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery.

    abstract:BACKGROUND:In addition to nitric oxide (NO) and prostacyclin (PGI2), the vascular endothelium can influence local vascular tone by a mechanism involving the hyperpolarization of vascular smooth muscle cells. This response is attributed to the release of an endothelium-derived hyperpolarizing factor (EDHF). The present ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2003.00910.x

    authors: Büssemaker E,Popp R,Binder J,Busse R,Fleming I

    更新日期:2003-05-01 00:00:00

  • The risks of vascular access.

    abstract::Fatal vascular access hemorrhage is considered a rare complication of hemodialysis (HD). Ellingson et al. indicate otherwise, and their data suggest that it causes 0.4-1.6% of deaths in US HD patients. It is more common with grafts than fistulas, and many victims have had previous access hemorrhages. The widespread pr...

    journal_title:Kidney international

    pub_type: 评论,杂志文章

    doi:10.1038/ki.2012.181

    authors: Blake PG,Quinn RR,Oliver MJ

    更新日期:2012-09-01 00:00:00

  • Role of platelet activating factor in kidney transplant rejection in the rat.

    abstract::Platelet activating factor (PAF) is a potent lipid mediator with a broad range of biologic activities. Experimental evidence suggests that PAF plays a role in the pathogenesis of a variety of inflammatory processes including allograft rejection. In this study, we evaluated the effects of the PAF antagonist BN52021 on ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1995.301

    authors: Butterly DW,Spurney RF,Ruiz P,Pirotzky E,Braquet P,Coffman TM

    更新日期:1995-08-01 00:00:00

  • Modulation of glomerular proteoglycans by insulin-like growth factor-1.

    abstract::Effect of insulin-like growth factor-1 (IGF) on the synthesis of glomerular proteoglycans (PGs) in an ex vivo recirculating organ perfusion system was investigated. Kidneys were perfused with a medium (approximately 80 ml) containing [35S]-sulfate (250 microCi/ml) and IGF (62.5 to 625 ng/ml). After radiolabeling, a sm...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1992.188

    authors: Watanabe Y,Kashihara N,Makino H,Kanwar YS

    更新日期:1992-05-01 00:00:00

  • Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.

    abstract:BACKGROUND:Hypertriglyceridemia is a result of reduced triglyceride (TG)-rich lipoprotein (TRL) catabolism and occurs in rats with nephrotic syndrome (NS) and in Nagase analbuminemic rats (NARs). While the heparin-releasable lipoprotein lipase (LpL) pool in NAR and in NS is similar, TG levels are significantly greater ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2001.00478.x

    authors: Shearer GC,Stevenson FT,Atkinson DN,Jones H,Staprans I,Kaysen GA

    更新日期:2001-01-01 00:00:00

  • Genotype-based changes in serum uric acid affect blood pressure.

    abstract::Elevated serum levels of uric acid consistently correlate with hypertension, but the directionality of the association remains debated. To help define this relationship, we used a controlled setting within a homogeneous Amish community and the Mendelian randomization of a nonsynonymous coding single-nucleotide polymor...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2011.414

    authors: Parsa A,Brown E,Weir MR,Fink JC,Shuldiner AR,Mitchell BD,McArdle PF

    更新日期:2012-03-01 00:00:00

  • Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.

    abstract::Primary hyperoxaluria is characterized by severe urolithiasis, nephrocalcinosis, and early renal failure. As treatment options are scarce, we aimed for a new therapeutic tool using colonic degradation of endogenous oxalate by Oxalobactor formigenes. Oxalobacter was orally administered for 4 weeks as frozen paste (IxOC...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章

    doi:10.1038/sj.ki.5001707

    authors: Hoppe B,Beck B,Gatter N,von Unruh G,Tischer A,Hesse A,Laube N,Kaul P,Sidhu H

    更新日期:2006-10-01 00:00:00

  • Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial.

    abstract:BACKGROUND:We hypothesized that increasing small solute clearance in peritoneal dialysis (PD) would lead to improvements in patient health-related quality of life (HRQOL). METHODS:Patients were randomized to a control group [standard 4 x 2 L continuous ambulatory peritoneal dialysis (CAPD)] and an intervention group (...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1523-1755.2005.00175.x

    authors: Paniagua R,Amato D,Vonesh E,Guo A,Mujais S,Mexican Nephrology Collaborative Study Group.

    更新日期:2005-03-01 00:00:00

  • Renal function and glomerular hemodynamics in male endotoxemic rats.

    abstract::The renal effects of a single intravenous dose of two different E. coli lipopolysaccharides (LPS 0111:B4 and LPS 0127:B8), at the same dose of 100 micrograms/kg, were evaluated in euvolemic Munich-Wistar (MW) rats by whole kidney clearance techniques and micropuncture studies. Following LPS infusion, a significant dec...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1989.232

    authors: Lugon JR,Boim MA,Ramos OL,Ajzen H,Schor N

    更新日期:1989-10-01 00:00:00

  • The impact of hepatitis C virus infection on renal allograft recipients.

    abstract::A second generation hepatitis C virus recombinant immunoblot assay (RIBA) was used to screen stored perioperative serum from 641 renal allograft recipients. One hundred and nine (17%) were anti-HCV positive at the time of transplant. RIBA positivity was found to be an independent predictor of post-transplant liver dis...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1994.29

    authors: Roth D,Zucker K,Cirocco R,DeMattos A,Burke GW,Nery J,Esquenazi V,Babischkin S,Miller J

    更新日期:1994-01-01 00:00:00

  • Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway.

    abstract::Proliferation of tubular epithelial cells underlies the development of cystic lesions and the subsequent impairment of renal function after renal mass reduction. The effect of HMG CoA reductase inhibitors (HRI) on cell proliferation was investigated in rat renal proximal tubular epithelial cells in primary culture. Tr...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1997.423

    authors: Vrtovsnik F,Couette S,Prié D,Lallemand D,Friedlander G

    更新日期:1997-10-01 00:00:00

  • Mast cell infiltration and chemokine expression in progressive renal disease.

    abstract:BACKGROUND:Mast cells are growth factor-rich, bone marrow-derived cells that infiltrate injured tissue where they have been implicated in the pathogenesis of progressive fibrosis. METHODS:Mast cell infiltration and the expression of related chemoattractants was examined following 5/6 nephrectomy, a model of progressiv...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2003.00183.x

    authors: Jones SE,Kelly DJ,Cox AJ,Zhang Y,Gow RM,Gilbert RE

    更新日期:2003-09-01 00:00:00

  • Mechanisms of altered renal perfusion in the early stage of obstructive jaundice.

    abstract::Mechanisms responsible for renal hemodynamic alterations were studied in jaundiced (by bile-duct ligation) rabbits (BDL) 10 days after ligation of the biliary tract, in comparison with sham-operated rabbits (SO). Arterial hematocrit, plasma volume, blood pressure, abdominal inferior vena cava pressure, and heart rate ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1980.25

    authors: Hishida A,Honda N,Sudo M,Nagase M

    更新日期:1980-02-01 00:00:00

  • Regulation of mesangial cell proliferation.

    abstract::Regardless of the source of injury, an imbalance in the control of mesangial cell proliferation appears to play a direct role in the degree of progressive renal injury and glomerulosclerosis. Some of the regulatory mechanisms include specific soluble or non-soluble extracellular factors and a complex array of receptor...

    journal_title:Kidney international

    pub_type: 杂志文章,评审

    doi:10.1046/j.1523-1755.1999.00710.x

    authors: Schöcklmann HO,Lang S,Sterzel RB

    更新日期:1999-10-01 00:00:00

  • Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.

    abstract:BACKGROUND:Interleukin-6 (IL-6) exerts its actions through a cell-surface receptor system that consists of two transmembrane subunits: the IL-6 binding glycoprotein gp 80 (IL-6R) and the signal-transducing component (gp 130). Soluble forms of the IL-6R (sIL-6R) are generated by shedding of the membrane-associated prote...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2000.00181.x

    authors: Memoli B,Postiglione L,Cianciaruso B,Bisesti V,Cimmaruta C,Marzano L,Minutolo R,Cuomo V,Guida B,Andreucci M,Rossi G

    更新日期:2000-07-01 00:00:00